- HER2 negative
- ER positive
- PR positive
- HER2 positive
- ER negative
- PD-L1 positive
- PR negative
- EGFR negative
- ALK negative
- KRAS positive
- Gleason Score 10
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Stage IV
- Stage III
- Stage II
- Stage I
- Adjuvant Therapy (except reconstruction)
- Cancer-Directed Surgery
- Endocrine Therapy (prescription with intent to initiate within 6 weeks after registration)
- Endocrine Therapy (within 6 months prior to registration)
- Endocrine Therapy within 6 months prior to registration
- Neo-Adjuvant Chemotherapy with No Residual Invasive Disease Post-Surgery
- Neo-adjuvant Chemotherapy
- Prescription with intent to initiate Endocrine Therapy within 6 weeks after registration
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
Disease Grade
225 trials
1
2
3
…12